Wednesday, November 28th

6.00 pm – 9.00 pm

Pre-Conference Reception

New Therapies - Lost in Translation?

Bruttel.jpg
Dr. Valentin Bruttel
Project Leader
AIM Biologicals, Universitätsklinikum Würzburg
Maas.jpg
Prof. Jochen Maas
Director Research & Development
Sanofi-Aventis Deutschland GmbH
Malek.jpg
Prof. Nisar Peter Malek
Chair Center for Personalised Medicine (ZPM)
University Hospital Tübingen

Moderated by

Abbott.jpg
Dr. Alison Abbott
Senior European Correspondent
Nature

Get-together – music, drinks and food

Alison Abbott

Abbott.jpg

Senior European Correspondent
Nature

Alison Abbot has a PhD in Pharmacology and has been Senior European Correspondent for Nature in Munich for over 20 years. She writes for different sections of Nature including editorials, news, features and the books and arts pages.

Many of her articles are about science politics in Europe, particularly Germany and Italy. Her specialist topic is neuroscience but she also covers other aspects of biology and health.

Prof. Jochen Maas

Maas.jpg

Director Research & Development
Sanofi-Aventis Deutschland GmbH

Jochen Maas was appointed General Manager, Research & Development (R&D) at Sanofi-Aventis Deutschland GmbH in 2010. He is a member of the Global R&D Management Board and of the German Management Board of Sanofi-Aventis.

Jochen Maas started his career in PK and later expanded his responsibilities to Preclinical Development, Preclinical and Clinical Development and Research & Development. He was also responsible for Global Research & Development in the Diabetes Division and acted as Vice President R&D Europe at Sanofi-Aventis.

Jochen Maas is a professor of pharmacokinetics and administering medication at Gießen-Friedberg University of Applied Sciences. He has studied biology and veterinary medicine at the Universities of Zurich, Heidelberg and Munich.

Prof. Nisar Peter Malek

Malek.jpg

Chair Center for Personalised Medicine (ZPM)
University Hospital Tübingen

08.12.1968, born in Hamburg

1989-1995, Study of Medicine, Hannover Medical School (MHH), Germany

10/91 - 9/93, MD thesis, Institute for Molecular Biology, MHH, (Thesis supervisor: Prof. Alfred Nordheim)

03/1996, Doctor of Medicine, MHH

01/98 - 1/01, Postdoctoral Fellow, Fred Hutchinson Cancer Research Center, Seattle, USA, (laboratory of Prof. James M. Roberts)

2002-07, Group leader at the Institute for Molecular Biology, MHH funded by the German Cancer Society (Max Eder Program)

4/2006, Board Cerified Internal Medicine

10/2006, Consultant in Internal Medicine Dept. of Gastroenterology, Hepatology and Endocrinology, MHH

05/2007, Venia Legendi “Internal Medicine”, MHH

03/2008, Professorship, Cell Proliferation Control, MHH

01/2009, Board Certified Internal Medicine and Gastroenterology

09/2011, Full professor in Internal Medicine and Gastroenterology. Director Dept. of Gastroenterology, Hepatology, Infectious Desease, University Hospital Tübingen, Germany

08/2014, Director Center for Personalized Medicine, Univ. Tübingen

08/2015, Managing Director Dept. of Internal Medicine, University Hospital Tübingen